Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents
Gadolinium(III) complexes are strong enhancers of magnetic resonance imaging (MRI) signals, thus are widely used as contrast agents despite their potential toxicity. Here, the authors review ligand design approaches aimed at improving the stability of Gd(III)-based MRI contrast agents.
Saved in:
Main Authors: | Thomas J. Clough, Lijun Jiang, Ka-Leung Wong, Nicholas J. Long |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/f20637c1e52446f1b3f9afd3a401fc33 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T1 relaxometry in patients with prostate cancer
by: Nikita Sushentsev, et al.
Published: (2020) -
Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement
by: Scott D Swanson, et al.
Published: (2008) -
PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT
by: Charmainne Cruje, et al.
Published: (2021) -
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
by: Estelrich J, et al.
Published: (2015) -
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma
by: Patil R, et al.
Published: (2020)